Professor Cass Byrnes discusses the treatment of cystic fibrosis patients with a CFTR modulator, and the evidence for the use of Trikafta

     Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) is funded for people aged 6 years and above with cystic fibrosis (CF), subject to eligibility criteria. 

    Professor Cass Byrnes MBChB, FRACP, MD (Auckland), GCCE (New South Wales) is in the Paediatric Department of the University of Auckland and a Paediatric Respiratory Specialist at Starship Children's Health and Kidz First Hospital.

    GORD – How to Optimise Management

     Presented by Gastroenterologist Alasdair Patrick

    Breakfast Session - Shared Care of the IBD Patient

     GPCME 2018 - Rotorua
    Sunday  June 10, 2018

    Presentations by:
    Drs Rick Stein and Ali Jafer (Consultant Gastroenterologists)
    Phoebe Wu and Jacqui Fletcher (IBD Nurses)

    In this Breakfast Session held at GPCME 2018, Dr Rick Stein discussed the growing burden of IBD in NZ.
     
    Dr Ali Jafer and Phoebe Wu also presented on the value of and models for shared care for the IBD patient, and Jacqui Fletcher gave tips for primary care clinicians on the best approaches to managing IBD patients.
     
    The video production for this presentation was funded by Emerge Health.

    IBD in Primary Care – Practical Management Tips

     GPCME 2018 - Rotorua
    Saturday June 9, 2018

    Presentation by:
    Dr David Rowbotham
    Consultant Gastroenterologist, Department of Gastroenterology and Hepatology, Auckland Hospital

    In this workshop held at GPCME 2018, Dr David Rowbotham presented tips for primary care clinicians on the best approaches to managing IBD patients in everyday practice.  He also discussed some novel therapies, stopping treatment and the IBD clinical trials taking place at the Auckland District Health Board.
     
    The video production for this presentation was funded by Emerge Health.